HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public health problem. Continuing propagation in endemic settings and emerging regional outbreaks have indicated the need for comprehensive and coordinated HIV prevention. We describe the development of a conceptual framework and calibration of an agent-based model (ABM) to examine how combinations of interventions may reduce and potentially eliminate HIV transmission among drug-using populations.A multidisciplinary team of researchers from epidemiology, sociology, geography, and mathematics developed a conceptual framework based on prior ethnographic and epidemiologic research. An ABM was constructed and calibrated through an iterative design and ver...
ObjectiveTo end the AIDS epidemic by 2030, despite the increasing poverty and inequalities, policies...
HIV prevention trials have demonstrated the effectiveness of a number of behavioral and biomedical i...
severe in the United States. Prevalence ranges up to 3.3 % in some groups. The aim of this study is ...
HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public he...
HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public he...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
New York City (NYC) remains an epicenter of the HIV epidemic in the United States. Given the variety...
BACKGROUND: New York City (NYC) remains an epicenter of the HIV epidemic in the United States. Given...
Progress in HIV (human immunodeficiency virus) prevention interventions has been made in recent year...
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
Recent studies that include newly developed protease inhibitors in the anti-HIV treatment regimen ha...
The transmission through contacts among MSM (men who have sex with men) is one of the dominating con...
ObjectiveTo end the AIDS epidemic by 2030, despite the increasing poverty and inequalities, policies...
ObjectiveTo end the AIDS epidemic by 2030, despite the increasing poverty and inequalities, policies...
HIV prevention trials have demonstrated the effectiveness of a number of behavioral and biomedical i...
severe in the United States. Prevalence ranges up to 3.3 % in some groups. The aim of this study is ...
HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public he...
HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public he...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
New York City (NYC) remains an epicenter of the HIV epidemic in the United States. Given the variety...
BACKGROUND: New York City (NYC) remains an epicenter of the HIV epidemic in the United States. Given...
Progress in HIV (human immunodeficiency virus) prevention interventions has been made in recent year...
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
Recent studies that include newly developed protease inhibitors in the anti-HIV treatment regimen ha...
The transmission through contacts among MSM (men who have sex with men) is one of the dominating con...
ObjectiveTo end the AIDS epidemic by 2030, despite the increasing poverty and inequalities, policies...
ObjectiveTo end the AIDS epidemic by 2030, despite the increasing poverty and inequalities, policies...
HIV prevention trials have demonstrated the effectiveness of a number of behavioral and biomedical i...
severe in the United States. Prevalence ranges up to 3.3 % in some groups. The aim of this study is ...